Gain of functions of RBMY in mouse fibroblast or in vivo in the liver results in vivo tumor formation [123, 124] downregulating RBMY in liver cancer cells reduces their tumorigenic potential [124]. This evidence concerns the gene RBMY1A1 and neoplasm.